Growth Metrics

Repligen (RGEN) Common Equity (2016 - 2025)

Historic Common Equity for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $2.1 billion.

  • Repligen's Common Equity rose 329.26% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 329.26%. This contributed to the annual value of $2.0 billion for FY2024, which is 40.07% up from last year.
  • Repligen's Common Equity amounted to $2.1 billion in Q3 2025, which was up 329.26% from $2.1 billion recorded in Q2 2025.
  • Over the past 5 years, Repligen's Common Equity peaked at $2.1 billion during Q3 2025, and registered a low of $1.6 billion during Q1 2021.
  • Its 5-year average for Common Equity is $1.9 billion, with a median of $2.0 billion in 2023.
  • Per our database at Business Quant, Repligen's Common Equity skyrocketed by 5248.56% in 2021 and then skyrocketed by 40.07% in 2024.
  • Repligen's Common Equity (Quarter) stood at $1.8 billion in 2021, then rose by 9.18% to $1.9 billion in 2022, then increased by 2.83% to $2.0 billion in 2023, then grew by 0.4% to $2.0 billion in 2024, then grew by 5.59% to $2.1 billion in 2025.
  • Its Common Equity stands at $2.1 billion for Q3 2025, versus $2.1 billion for Q2 2025 and $2.0 billion for Q1 2025.